Solstice Neurosciences' Series B Round

Solstice Neurosciences raised a round of funding on November 09, 2006.

Founded in 2004, Solstice Neurosciences, Inc. is a biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty products. Solstice's first product, Myobloc (Bo…

Articles about Solstice Neurosciences' Series B Round: